JPRN-UMIN000033940已完成3 期
A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease. - PD001J
Medical Corporation Tokushukai Shonanfujisawa Tokushukai hospital0 个研究点目标入组 10 人开始时间: 2018年9月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Subjects with unstable cardiac status including: 2.Subjects exhibiting any behavior 3.Severe hypertension. 4.Subjects with standard contraindications for MR imaging 5.Significant claustrophobia that cannot be managed with mild medication. 6.Current medical condition resulting in abnormal bleeding and/or coagulopathy 7.Patient with severely impaired renal function with estimated glomerular filtration 8.Receiving anticoagulant (e.g. warfarin) or antiplatelet (e.g. aspirin) therapy within one week of focused ultrasound 9.Subjects with risk factors for intraoperative or postoperative bleeding 10 Subjects who have an Overall Skull Density Ratio of 0.30 or less as calculated from the screening CT.
研究者
相似试验
已完成
不适用
A feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Essential TremorJPRN-UMIN000009613Tokyo Women's Medical University Shin-yurigaoka general hospital10
招募中
1 期
It is a study in a type of blood cancer patients. In this we will add a new medicine called Ruxolitinib in the treatment and see the results.CTRI/2021/02/031251Tata Research Administrative Council TRAC
已完成
不适用
se of a Topical Skin Adhesive to close Wounds from Surgical IncisionsCTRI/2017/06/008795Medical Adhesive Revolution GmbH10
Unknown
1 期
Study for a new minimally invasive system to treat chronic sinusitisCTRI/2015/12/006445InnAccel Acceleration Services
进行中（未招募）
1 期
Sonodynamic therapy using Focused Ultrasound and 5-ala in the treatment of glioblastomas.EUCTR2021-003374-30-ITFONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA10